KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Equity (2016 - 2025)

Resmed (RMD) has disclosed Return on Equity for 16 consecutive years, with 0.24% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity changed 0.0% year-over-year to 0.24%, compared with a TTM value of 0.24% through Dec 2025, changed 0.0%, and an annual FY2025 reading of 0.26%, up 3.0% over the prior year.
  • Return on Equity was 0.24% for Q4 2025 at Resmed, roughly flat from 0.24% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.3% in Q2 2021 and bottomed at 0.2% in Q4 2023.
  • Average Return on Equity over 5 years is 0.24%, with a median of 0.24% recorded in 2022.
  • The sharpest move saw Return on Equity decreased -7bps in 2022, then rose 4bps in 2024.
  • Year by year, Return on Equity stood at 0.27% in 2021, then fell by -15bps to 0.23% in 2022, then dropped by -10bps to 0.2% in 2023, then rose by 17bps to 0.24% in 2024, then dropped by 0bps to 0.24% in 2025.
  • Business Quant data shows Return on Equity for RMD at 0.24% in Q4 2025, 0.24% in Q3 2025, and 0.24% in Q2 2025.